Jiyeon Suh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiyeon Suh has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Jeehyun Lee
School of Mathematics and Computing (Mathematics), Yonsei University, Seoul, Republic of Korea
3 shared publications - Jae-Ki Choi
Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
2 shared publications - Sun Hee Park
Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
2 shared publications - Changsoo Kim
Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Institute for Environmental Research, Yonsei University College of Medicine, Seoul, Republic of Korea; Institute of Human Complexity and Systems Science, Yonsei University, Incheon, Republic of Korea
1 shared publication Jeffrey Shaman
Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University
1 shared publication- Jong Dae Kim
Department of Burn Reconstructive Surgery, Daejeon Hwa Hospital, Daejeon, Republic of Korea
1 shared publication
Latest Publications
- Open Access
COVID-19 transmission dynamics in South Korea prior to vaccine distribution
In early 2020, South Korea experienced a large coronavirus disease 2019 (COVID-19) outbreak. However, despite its proximity to China, where the virus had emerged, and the high population density of the Seoul metropolitan area, a major international hub, South Korea effectively contained the spread of COVID-19 using non-pharmaceutical interventions until vaccine distribution in 2021. Here, we built a metapopulation model with a susceptible-exposed-infectious-quarantined-recovered (SEIQR) structure and combined it with the ensemble adjustment Kalman filter to infer the transmission dynamics of COVID-19 in South Korea from February 2020 until vaccine deployment. Over the study period, the fraction of documented infections (ascertainment rate) was found to increase from 0.50 (95% credible interval (CI): 0.26—0.77) to 0.62 (95% CI: 0.39—0.86). The cumulative number of total infections, including both documented cases and undocumented infections, was less than 1% of the South Korean population at the end of the simulation period, indicating that the majority of people had yet to be infected when vaccine administration began. These findings enhance understanding of the COVID-19 outbreak in South Korea and highlight the importance of preparedness and response in managing global pandemics.
Open AccessCOVID-19 transmission dynamics in South Korea prior to vaccine distribution
In early 2020, South Korea experienced a large coronavirus disease 2019 (COVID-19) outbreak. However, despite its proximity to China, where the virus had emerged, and the high population density of the Seoul metropolitan area, a major international hub, South Korea effectively contained the spread of COVID-19 using non-pharmaceutical interventions until vaccine distribution in 2021. Here, we built a metapopulation model with a susceptible-exposed-infectious-quarantined-recovered (SEIQR) structure and combined it with the ensemble adjustment Kalman filter to infer the transmission dynamics of COVID-19 in South Korea from February 2020 until vaccine deployment. Over the study period, the fraction of documented infections (ascertainment rate) was found to increase from 0.50 (95% credible interval (CI): 0.26—0.77) to 0.62 (95% CI: 0.39—0.86). The cumulative number of total infections, including both documented cases and undocumented infections, was less than 1% of the South Korean population at the end of the simulation period, indicating that the majority of people had yet to be infected when vaccine administration began. These findings enhance understanding of the COVID-19 outbreak in South Korea and highlight the importance of preparedness and response in managing global pandemics.
- Open Access
- 15 June 2022
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 18 (5) , 2085468
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling
In South Korea, despite the implementation of a universal single-dose vaccination program for children aged 12–15 months in 2005, the varicella incidence rate remains significant. Prior case-control studies have reported that currently used varicella vaccines are extremely inefficacious. We estimated vaccine effectiveness (VE) by fitting a dynamic transmission model to age-specific varicella incidence data from 2007 to 2015 and available vaccine coverage data. The initial vaccine efficacy and primary failure rates were estimated to be 61.1% and 38.9%, respectively. The average duration of protection was 21.4 years. The mean VE [(1-relative risk) %] for the simulated data of 2004–2014 birth cohorts decreased from 59.8% to 50.7% over 9 years. This mathematical modeling study demonstrated that the single-dose vaccine exhibits moderate effectiveness, and a high proportion of primary failure could be a main cause of breakthrough infections. Therefore, a two-dose vaccination strategy should be considered.
- 15 June 2022
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 18 (5) , 2085468
Open AccessEstimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling
In South Korea, despite the implementation of a universal single-dose vaccination program for children aged 12–15 months in 2005, the varicella incidence rate remains significant. Prior case-control studies have reported that currently used varicella vaccines are extremely inefficacious. We estimated vaccine effectiveness (VE) by fitting a dynamic transmission model to age-specific varicella incidence data from 2007 to 2015 and available vaccine coverage data. The initial vaccine efficacy and primary failure rates were estimated to be 61.1% and 38.9%, respectively. The average duration of protection was 21.4 years. The mean VE [(1-relative risk) %] for the simulated data of 2004–2014 birth cohorts decreased from 59.8% to 50.7% over 9 years. This mathematical modeling study demonstrated that the single-dose vaccine exhibits moderate effectiveness, and a high proportion of primary failure could be a main cause of breakthrough infections. Therefore, a two-dose vaccination strategy should be considered.
- Open Access
- 1 January 2022
- Published by XMLink in Journal of Korean Medical Science
- Vol. 37 (27) , e212
Cost-Benefit Analysis of Tafenoquine for Radical Cure of Plasmodium vivax Malaria in Korea
Suh J, et al. J Korean Med Sci. 2022 Jun;37(27):e212. https://doi.org/10.3346/jkms.2022.37.e212
- 1 January 2022
- Published by XMLink in Journal of Korean Medical Science
- Vol. 37 (27) , e212
Open AccessCost-Benefit Analysis of Tafenoquine for Radical Cure of Plasmodium vivax Malaria in Korea
Suh J, et al. J Korean Med Sci. 2022 Jun;37(27):e212. https://doi.org/10.3346/jkms.2022.37.e212
- 8 April 2021
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 17 (8) , 2488-2493
Estimating the basic reproductive number of varicella in South Korea incorporating social contact patterns and seroprevalence
Varicella, which is caused by the varicella zoster virus (VZV), is a common infectious disease affecting children. Varicella vaccines have been used for decades; however, vaccination policies vary across countries because of differences in VZV epidemiology. The basic reproductive number a transmissibility measure parameter, also differs from country to country. In this study for varicella was estimated in South Korea using the contact rate matrix derived from averaged POLYMOD contact data, the Korean population, and proportionality factor fitted to the Korean VZV seroprevalence for varicella in South Korea was estimated to be 5.67 (95% CI: 5.33, 6.33). Therefore, to reach the herd immunity threshold, the critical vaccine coverage should be greater than 82.4% with a perfect vaccine, or the primary vaccine failure proportion should be less than 17.6% with 100% coverage. Because of the relatively low seroconversion rate and rapidly waning immunity after one-dose vaccination in South Korea, the herd immunity threshold is difficult to attain with only a one-dose vaccine. Two doses of vaccination may be necessary to effectively interrupt varicella transmission and maintain herd immunity in South Korea. The study results can help guide the decision-making on an effective varicella vaccination policy in South Korea.- 8 April 2021
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 17 (8) , 2488-2493
Estimating the basic reproductive number of varicella in South Korea incorporating social contact patterns and seroprevalence
Varicella, which is caused by the varicella zoster virus (VZV), is a common infectious disease affecting children. Varicella vaccines have been used for decades; however, vaccination policies vary across countries because of differences in VZV epidemiology. The basic reproductive number a transmissibility measure parameter, also differs from country to country. In this study for varicella was estimated in South Korea using the contact rate matrix derived from averaged POLYMOD contact data, the Korean population, and proportionality factor fitted to the Korean VZV seroprevalence for varicella in South Korea was estimated to be 5.67 (95% CI: 5.33, 6.33). Therefore, to reach the herd immunity threshold, the critical vaccine coverage should be greater than 82.4% with a perfect vaccine, or the primary vaccine failure proportion should be less than 17.6% with 100% coverage. Because of the relatively low seroconversion rate and rapidly waning immunity after one-dose vaccination in South Korea, the herd immunity threshold is difficult to attain with only a one-dose vaccine. Two doses of vaccination may be necessary to effectively interrupt varicella transmission and maintain herd immunity in South Korea. The study results can help guide the decision-making on an effective varicella vaccination policy in South Korea.